business development

Fierce Pharma

AbbVie will continue to pursue external innovation for long-term

Amid reports that AbbVie is angling for a $1B buyout of neuroscience specialist Gilgamesh, the company revealed booming sales of Skyrizi and Rinvoq.

Kevin Dunleavy Jul 31, 2025 11:44am

Eli Lilly

Catalyze360 aims to expand beyond Lilly's core drug ethos

Aug 19, 2024 9:43am

Bayer

Bayer pharma BD chief says group overhaul not slowing deals

Aug 15, 2024 2:30pm

rhino charge bold attack full speed

Biogen CEO said no risky deals in 2023. Now he’s ready to be bold

Aug 1, 2024 10:34am

Johnson Johnson JJ

J&J hooks Proteologix for at least $850M in cash

May 16, 2024 10:12am

Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together

Geopolitics threatens Chinese biotechs' hot out-licensing biz

Apr 11, 2024 4:00am